Back to resultsA Study of Meditation as a Treatment for Epilepsy
Primary Purpose
Epilepsy
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Meditation
Sponsored by
About this trial
This is an interventional treatment trial for Epilepsy
Eligibility Criteria
Inclusion Criteria: 6 or more seizures per month ability to participate in meditation
Sites / Locations
- Geffen School of Medicine at UCLA
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Meditation
Arm Description
Outcomes
Primary Outcome Measures
Seizure frequency
Quality of Life
Secondary Outcome Measures
Mood
Affect
Anxiety
Sleep quality
Full Information
NCT ID
NCT00370929
First Posted
August 30, 2006
Last Updated
July 20, 2016
Sponsor
University of California, Los Angeles
1. Study Identification
Unique Protocol Identification Number
NCT00370929
Brief Title
A Study of Meditation as a Treatment for Epilepsy
Official Title
Treatment of Epilepsy by Meditation and Cultivation of Emotional Balance
Study Type
Interventional
2. Study Status
Record Verification Date
July 2016
Overall Recruitment Status
Completed
Study Start Date
May 2006 (undefined)
Primary Completion Date
January 2008 (Actual)
Study Completion Date
January 2008 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of California, Los Angeles
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Epileptic seizures may occur at times of stress and commonly increase life stress. This study will evaluate whether meditation improves seizure control and quality of life for individuals with uncontrolled epilepsy.
Detailed Description
Individuals who have uncontrolled epilepsy commonly experience disability, depression, anxiety and injuries from seizures. For such individuals, ideal treatments should improve quality of life through control of seizures and improved emotional state. Meditation with cultivation of emotional balance is known to improve emotional state and may also benefit seizure control in some individuals. In this study, individuals with uncontrolled epilepsy will receive detailed training in meditation to determine whether the training leads to improvements in seizure control and various measures of emotion and quality of life.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Epilepsy
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
8 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Meditation
Arm Type
Experimental
Intervention Type
Behavioral
Intervention Name(s)
Meditation
Primary Outcome Measure Information:
Title
Seizure frequency
Time Frame
20 weeks
Title
Quality of Life
Time Frame
20 weeks
Secondary Outcome Measure Information:
Title
Mood
Time Frame
20 weeks
Title
Affect
Time Frame
20 weeks
Title
Anxiety
Time Frame
20 weeks
Title
Sleep quality
Time Frame
20 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
6 or more seizures per month
ability to participate in meditation
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
John Stern, MD
Organizational Affiliation
University of California, Los Angeles
Official's Role
Principal Investigator
Facility Information:
Facility Name
Geffen School of Medicine at UCLA
City
Los Angeles
State/Province
California
ZIP/Postal Code
90095
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
A Study of Meditation as a Treatment for Epilepsy
We'll reach out to this number within 24 hrs